The proinflammatory cytokines IL-1, IL-6, and Oncostatin M all significantly upregulated C4BP expressions in the HepG-2 hepatoma cell line (284), suggesting an interplay between inflammation-driven regulation of complement components shielding the tumor from cytotoxic effectors. Here, IL1A is linked to hepatocellular carcinoma.